Oak Harbor Wealth Partners LLC Sells 164 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Oak Harbor Wealth Partners LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,676 shares of the healthcare conglomerate’s stock after selling 164 shares during the quarter. Oak Harbor Wealth Partners LLC’s holdings in UnitedHealth Group were worth $882,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. BlackDiamond Wealth Management LLC grew its position in shares of UnitedHealth Group by 31.7% during the 4th quarter. BlackDiamond Wealth Management LLC now owns 777 shares of the healthcare conglomerate’s stock worth $391,000 after purchasing an additional 187 shares in the last quarter. WBI Investments LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $2,015,000. Annis Gardner Whiting Capital Advisors LLC grew its position in shares of UnitedHealth Group by 7.5% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 986 shares of the healthcare conglomerate’s stock worth $519,000 after purchasing an additional 69 shares in the last quarter. Frazier Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $353,000. Finally, Tidemark LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $347,000. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Bank of America restated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. TD Cowen cut their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Finally, Truist Financial reaffirmed a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Down 1.2 %

Shares of NYSE UNH traded down $6.04 during mid-day trading on Thursday, reaching $515.31. 1,380,310 shares of the company’s stock traded hands, compared to its average volume of 4,168,246. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The stock has a market cap of $474.29 billion, a P/E ratio of 31.64, a PEG ratio of 1.52 and a beta of 0.55. The business has a 50-day simple moving average of $488.32 and a 200 day simple moving average of $511.06. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company earned $6.26 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.46%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.